60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
6
|
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
|
US |
|
E.ON SE
LSE:0MPP
|
DE |
|
Microvast Holdings Inc
NASDAQ:MVST
|
US |
|
Puuilo Oyj
F:8JQ
|
FI |
|
R
|
Rexel SA
SWB:E7V
|
FR |
|
Springer Nature AG & Co KgaA
OTC:SPGDF
|
DE |
|
Quanterix Corp
NASDAQ:QTRX
|
US |
|
Longfor Group Holdings Ltd
HKEX:960
|
CN |
Wall St Price Targets
SXTP Price Targets Summary
60 Degrees Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for SXTP is 3.77 USD with a low forecast of 3.74 USD and a high forecast of 3.89 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SXTP's stock price target?
Price Target
3.77
USD
According to Wall Street analysts, the average 1-year price target for SXTP is 3.77 USD with a low forecast of 3.74 USD and a high forecast of 3.89 USD.
What is the Revenue forecast for 60 Degrees Pharmaceuticals Inc?
Projected CAGR
7%
Over the last 4 years, the compound annual growth rate for Revenue has been -31%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for 60 Degrees Pharmaceuticals Inc?
Projected CAGR
21%
Over the last 4 years, the compound annual growth rate for Gross Profit has been -42%. The projected CAGR for the next 3 years is 21%.
